1. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of
Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624-631.PMID:
17638799.
2. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for
Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.PMID:
20307191.
3. Lee JK, Cho JY, Kim YS, et al. Comparative value of sigmoidoscopy and stool cytotoxin-A assay for diagnosis of pseudomembranous colitis. Intest Res 2005;3:61-67.
4. Pepin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of
Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-1597.PMID:
15889355.
5. Jawa RS, Mercer DW.
Clostridium difficile-associated infection: a disease of varying severity. Am J Surg 2012;204:836-842.PMID:
23036604.
6. Wenisch JM, Schmid D, Tucek G, et al. A prospective cohort study on hospital mortality due to
Clostridium difficile infection. Infection 2012;40:479-484.PMID:
22527876.
7. Bloomfield MG, Sherwin JC, Gkrania-Klotsas E. Risk factors for mortality in
Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect 2012;82:1-12.PMID:
22727824.
8. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of
Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-1084.PMID:
16182895.
9. Diggs NG, Surawicz CM. Evolving concepts in
Clostridium difficile colitis. Curr Gastroenterol Rep 2009;11:400-405.PMID:
19765368.
10. Miller M, Gravel D, Mulvey M, et al. Health care-associated
Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194-201.PMID:
20025526.
11. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of
Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590.PMID:
15889354.
12. Kim YS, Han DS, Kim YH, et al. Incidence and clinical features of
Clostridium difficile infection in Korea: a nationwide study. Epidemiol Infect 2013;141:189-194.PMID:
22717061.
13. Lee JH, Lee SY, Kim YS, et al. The incidence and clinical features of
Clostridium difficile infection; single center study. Korean J Gastroenterol 2010;55:175-182.PMID:
20357528.
14. Ryu HS, Kim YS, Seo GS, Lee YM, Choi SC. Risk factors for recurrent
Clostridium difficile infection. Intest Res 2012;10:176-182.
15. Choi HK, Kim KH, Lee SH, Lee SJ. Risk factors for recurrence of
Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization. J Korean Med Sci 2011;26:859-864.PMID:
21738336.
16. Jung KS, Park JJ, Chon YE, et al. Risk factors for treatment failure and recurrence after metronidazole treatment for
Clostridium difficile-associated diarrhea. Gut Liver 2010;4:332-337.PMID:
20981209.
17. Tae CH, Jung SA, Song HJ, et al. The first case of antibiotic-associated colitis by
Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci 2009;24:520-524.PMID:
19543521.
18. Kim J, Kang JO, Kim H, et al. Epidemiology of
Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 2013;19:521-527.PMID:
22712697.
19. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for
Clostridium difficile disease. JAMA 1994;271:1913-1918.PMID:
8201735.
20. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent
Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999;20:43-50.PMID:
9927265.
21. Gerding DN. Treatment of
Clostridium difficile-associated diarrhea and colitis. Curr Top Microbiol Immunol 2000;250:127-139.PMID:
10981361.
22. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of
Clostridium difficile-associated diarrhea. J Clin Microbiol 2000;38:2386-2388.PMID:
10835010.
23. Bauer MP, Notermans DW, van Benthem BH, et al.
Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011;377:63-73.PMID:
21084111.
24. Seo GS.
Clostridium difficile infection: what's new? Intest Res 2013;11:1-13.
25. Musher DM, Nuila F, Logan N. The long-term outcome of treatment of
Clostridium difficile colitis. Clin Infect Dis 2007;45:523-524.PMID:
17638211.
26. Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent
Clostridium difficile infection. J Hosp Infect 2008;70:298-304.PMID:
18951661.
27. Johnson S. Recurrent
Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009;58:403-410.PMID:
19394704.
28. Pepin J, Valiquette L, Alary ME, et al.
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-472.PMID:
15337727.
29. O'Connor JR, Johnson S, Gerding DN.
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009;136:1913-1924.PMID:
19457419.
30. Kim H, Jeong SH, Roh KH, et al. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of
Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med 2010;30:491-497.PMID:
20890081.
31. Kim J, Pai H, Seo MR, Kang JO. Epidemiology and clinical characteristics of
Clostridium difficile infection in a Korean tertiary hospital. J Korean Med Sci 2011;26:1258-1264.PMID:
22022175.
32. Walters BA, Roberts R, Stafford R, Seneviratne E. Relapse of antibiotic associated colitis: endogenous persistence of
Clostridium difficile during vancomycin therapy. Gut 1983;24:206-212.PMID:
6826104.
33. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985;80:867-868.PMID:
4050760.
34. Wilcox MH, Fawley WN, Settle CD, Davidson A. Recurrence of symptoms in
Clostridium difficile infection--relapse or reinfection? J Hosp Infect 1998;38:93-100.PMID:
9522287.
35. O'Neill GL, Beaman MH, Riley TV. Relapse versus reinfection with
Clostridium difficile. Epidemiol Infect 1991;107:627-635.PMID:
1752311.
36. Maroo S, Lamont JT. Recurrent
Clostridium difficile. Gastroenterology 2006;130:1311-1316.PMID:
16618421.
37. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of
Clostridium difficile and
Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998;129:1012-1019.PMID:
9867755.
38. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent
Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002.PMID:
22002980.